122 THE US-ISRAEL | Legal Review 2025/26 and documentation supporting prospectus claims. Companies should assemble these materials well in advance of the initial SEC filing. How Lowenstein Sandler Can Help With 2026 shaping up to be a breakout year for Israeli companies in the US capital markets, now is the time to prepare. Lowenstein Sandler is uniquely positioned to guide Israeli companies through every stage of the process—from early-stage planning through listing and beyond. With deep expertise in capital markets transactions; extensive experience in the technology, artificial intelligence, digital assets, fintech, defense tech, and life sciences sectors; and a proven track record advising Israeli companies and investors, we provide strategic, solutions-oriented counsel tailored to the needs of high-growth businesses. Our long-standing relationships with key market players—including investment banks, institutional investors, and leading Israeli law firms—enable us to deliver seamless, pragmatic advice that balances legal complexities with business realities. Whether preparing for an IPO; structuring a SPAC, de-SPAC, or reverse merger transaction; navigating new FPI reporting requirements; or addressing corporate governance and ongoing SEC obligations, Lowenstein Sandler delivers the insight, execution, and commitment that Israeli companies need in order to capitalize on the opportunities ahead. The window is open—let us help you move decisively.
RkJQdWJsaXNoZXIy MjgzNzA=